PET/MRI: Paving the way for the next generation of clinical multimodality imaging applications

Journal of Nuclear Medicine

Volumn 51, Issue 3, 2010, Pages 333-336

  Pichler, Bernd J ^a   Kolb, Armin ^a   Nägele, Thomas ^a   Schlemmer, Heinz Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Arterial spin labeling (ASL); Clinical multimodality imaging; CT; fMRI; Magnetic resonance tomograph (MRT); MR PET; PET; PET CT; PET MRI; Positron emission tomography; Spectroscopy

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; ADULT; AGED; ARTICLE; BRAIN TUMOR; FEMALE; LIVER TUMOR; MENINGIOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; SCINTISCANNING; WHOLE BODY IMAGING;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MENINGIOMA; MIDDLE AGED; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; WHOLE BODY IMAGING;

EID: 77950366807     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.061853     Document Type: Review

References (25)

1. Pichler BJ, Wehrl HF, Judenhofer MS. Latest advances in molecular imaging instrumentation. J Nucl Med. 2008;49(suppl 2):5S-23S.
2. Karp JS, Surti S, Daube-Witherspoon ME, Muehllehner G. Benefit of time-of-flight in PET: experimental and clinical results. J Nucl Med. 2008;49:462-470. (Pubitemid 351355213)
3. Mawlawi O, Townsend DW. Multimodality imaging: an update on PET/CT technology. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S15-S29.
4. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379. (Pubitemid 30643379)
5. Townsend DW, Beyer T. A combined PET/CT scanner: the path to true image fusion. Br J Radiol. 2002;75(spec no):S24-S30. (Pubitemid 35446444)
6. Wiesinger F, Van de Moortele PF, Adriany G, De Zanche N, Ugurbil K, Pruessmann KP. Potential and feasibility of parallel MRI at high field. NMR Biomed. 2006;19:368-378. (Pubitemid 43811110)
7. Shao Y, Cherry SR, Farahani K, et al. Simultaneous PET and MR imaging. Phys Med Biol. 1997;42:1965-1970.
8. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14:459-465.
9. Schlemmer HP, Pichler BJ, Schmand M, et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology. 2008;248:1028-1035.
10. Hofmann M, Pichler B, Scholkopf B, Beyer T. Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S93-S104.
11. Hofmann M, Steinke F, Scheel V, et al. MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med. 2008;49:1875-1883.
12. Martinez-Moller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med. 2009;50:520-526.
13. von Schulthess GK, Schlemmer HP. A look ahead: PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S3-S9.
14. Townsend DW. Dual-modality imaging: combining anatomy and function. J Nucl Med. 2008;49:938-955.
15. Schlemmer HP, Schafer J, Pfannenberg C, et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol. 2005;40:64-71. (Pubitemid 40144410)
16. 18F-FDG PET/CT examinations. J Nucl Med. 2005; 46:608-613.
17. Huang B, Law MW, Khong PL. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology. 2009;251:166-174.
18. Heiss WD. The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S105-S112.
19. Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol. 2002;12:2091-2099.
20. Muller-Horvat C, Radny P, Eigentler TK, et al. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer. 2006;42:342-350. (Pubitemid 43132889)
21. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer. 2007;43:557-564.
22. Schmidt GP, Baur-Melnyk A, Herzog P, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol. 2005;40:743-753. (Pubitemid 41690430)
23. Antoch G, Vogt FM, Freudenberg LS, et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290:3199-3206. (Pubitemid 38020681)
24. 15O-water PET imaging. J Nucl Med. 2008;49:1723-1729.
25. Nekolla SG, Martinez-Moeller A, Saraste A. PET and MRI in cardiac imaging: from validation studies to integrated applications. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S121-S130.